ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 133 filers reported holding ARCUS BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,288,838 | -9.8% | 517,484 | +2.0% | 0.00% | 0.0% |
Q2 2023 | $10,303,567 | +6.4% | 507,315 | -4.5% | 0.00% | 0.0% |
Q1 2023 | $9,684,985 | -34.1% | 530,975 | -25.3% | 0.00% | -33.3% |
Q4 2022 | $14,695,663 | -18.9% | 710,622 | +2.5% | 0.00% | -25.0% |
Q3 2022 | $18,130,000 | +5.0% | 693,008 | +1.7% | 0.00% | 0.0% |
Q2 2022 | $17,270,000 | -8.9% | 681,550 | +13.5% | 0.00% | +33.3% |
Q1 2022 | $18,948,000 | -25.0% | 600,408 | -3.8% | 0.00% | -25.0% |
Q4 2021 | $25,264,000 | +13.2% | 624,270 | -2.5% | 0.00% | 0.0% |
Q3 2021 | $22,325,000 | +21.7% | 640,232 | -4.2% | 0.00% | +33.3% |
Q2 2021 | $18,348,000 | +30.5% | 668,181 | +33.4% | 0.00% | 0.0% |
Q1 2021 | $14,063,000 | +1.2% | 500,846 | -6.5% | 0.00% | 0.0% |
Q4 2020 | $13,903,000 | +46.8% | 535,565 | -3.1% | 0.00% | +50.0% |
Q3 2020 | $9,469,000 | -21.4% | 552,448 | +13.4% | 0.00% | -33.3% |
Q2 2020 | $12,050,000 | +116.1% | 487,083 | +21.2% | 0.00% | +50.0% |
Q1 2020 | $5,577,000 | +42.7% | 401,831 | +3.9% | 0.00% | +100.0% |
Q4 2019 | $3,907,000 | +18.0% | 386,867 | +6.3% | 0.00% | 0.0% |
Q3 2019 | $3,311,000 | +25.3% | 363,822 | +9.5% | 0.00% | 0.0% |
Q2 2019 | $2,642,000 | -32.5% | 332,256 | +6.0% | 0.00% | 0.0% |
Q1 2019 | $3,916,000 | +19.9% | 313,560 | +3.4% | 0.00% | 0.0% |
Q4 2018 | $3,265,000 | +125.5% | 303,109 | +191.6% | 0.00% | – |
Q3 2018 | $1,448,000 | +87.1% | 103,934 | +64.5% | 0.00% | – |
Q2 2018 | $774,000 | – | 63,199 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |